GSK’s partner Hansoh Pharma succeeds in Chinese Phase III SCLC ADC trial
GSK signed an exclusive licence deal with Hansoh Pharma in 2023, laying out up to $1.71bn in an upfront payment plus milestones.
13 July 2026
13 July 2026
GSK signed an exclusive licence deal with Hansoh Pharma in 2023, laying out up to $1.71bn in an upfront payment plus milestones.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.